| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.2M | -70.0% |
| Cost of Revenue | $53.6M | -67.2% |
| R&D Expense | $18.4M | +35.1% |
| SG&A Expense | $14.4M | -1.7% |
| Operating Income | -$53.5M | +36.3% |
| Interest Expense | $18.5M | -10.3% |
| Pre-tax Income | -$60.8M | +32.5% |
| Income Tax | $0 | +100.0% |
| Net Income | -$60.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.0M | +1050.4% |
| Accounts Receivable | $2.8M | — |
| Inventory | $2.8M | -74.6% |
| Current Assets | $152.4M | +307.6% |
| Total Assets | $249.0M | +74.9% |
| Current Liabilities | $12.0M | -61.5% |
| Long-term Debt | $135.0M | -15.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.9M | +5.9% |
| Capital Expenditures | $951K | -86.4% |
| Investing Cash Flow | $8.3M | +221.3% |
| Financing Cash Flow | $155.8M | +2936.7% |
| Free Cash Flow | -$35.8M | +18.7% |
| +31.3% |
| EPS (Basic) | -$0.36 | +75.5% |
| EPS (Diluted) | -$0.36 | +75.5% |
| Total Liabilities |
| $185.6M |
| -11.9% |
| Stockholders' Equity | $63.3M | +192.4% |